Global Kinetic Analysis of Proteolysis Via Quantitative Targeted Proteomics

Total Page:16

File Type:pdf, Size:1020Kb

Global Kinetic Analysis of Proteolysis Via Quantitative Targeted Proteomics Global kinetic analysis of proteolysis via quantitative targeted proteomics Nicholas J. Agarda,b, Sami Mahrusa,c, Jonathan C. Trinidada, Aenoch Lynna,d, Alma L. Burlingamea, and James A. Wellsa,e,1 aDepartment of Pharmaceutical Chemistry, University of California, San Francisco, 1700 4th Street, San Francisco, CA 94114; bDepartment of Biocatalyst Characterization and Design, Codexis Inc., 200 Penobscot Drive, Redwood City, CA 94063-4718; cDepartment of Biomarker Research, Genentech, 1 DNA Way, South San Francisco, CA 94010; dDuke Translational Medicine Institute, Duke University Medical Center, Durham, NC 27710; and eDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, 1700 4th Street, San Francisco, CA 94114 Edited by* Robert T. Sauer, Massachusetts Institute of Technology, Cambridge, MA, and approved December 14, 2011 (received for review October 17, 2011) Mass spectrometry-based proteomics is a powerful tool for identi- ples with less complexity than those derived from the whole pro- fying hundreds to thousands of posttranslational modifications in teome, decreasing the likelihood of misassignment. Here, we complex mixtures. However, it remains enormously challenging to have applied SRM analysis to the N-terminal isolation technology k ∕K simultaneously assess the intrinsic catalytic efficiencies ( cat M)of to determine the time-course of caspase-mediated proteolysis. these modifications in the context of their natural interactors. Such From these data we calculated catalytic efficiencies for hundreds fundamental enzymological constants are key to determining sub- of caspase substrates in parallel. We believe these data will allow strate specificity and for establishing the timing and importance of a more quantitative systems-level understanding of the funda- cellular signaling. Here, we report the use of selected reaction mon- mental process of cell death, and move us closer to understanding itoring (SRM) for tracking proteolysis induced by human apoptotic the global enzymology of posttranslational modifications. caspases-3, -7, -8, and -9 in lysates and living cells. By following the appearance of the cleaved peptides in lysate as a function of time, Results and Discussion we were able to determine hundreds of catalytic efficiencies in To globally assess caspase catalytic efficiencies in complex mix- parallel. Remarkably, we find the rates of substrate hydrolysis for tures, we quantified the appearance of caspase-cleaved N termini individual caspases vary greater than 500-fold indicating a sequen- in two complementary experiments. First, in cell lysates with tial process. Moreover, the rank-order of substrate cutting is similar endogenous caspases inactivated, we tracked the time-dependent in apoptotic cells, suggesting that cellular structures do not drama- activities of exogenously added executioner caspases-3 or -7, or tically alter substrate accessibility. Comparisons of extrinsic (TRAIL) extrinsic and intrinsic initiator caspases-8 or -9. Second, we com- and intrinsic (staurosporine) inducers of apoptosis revealed similar pared these results to the rates of appearance of caspase-cleaved substrate profiles, suggesting the final proteolytic demolitions pro- peptides in cells treated with different apoptosis-inducing drugs. ceed by similarly ordered plans. Certain biological processes were Experiments in cell lysates reveal the priority of substrate cleavage rapidly targeted by the caspases, including multiple components with a resolution that is unavailable in bulk cellular studies due of the endocyotic pathway and miRNA processing machinery. We to the stochasticity of mitochondrial permeablization and caspase believe this massively parallel and quantitative label-free approach activation (8). Additionally, the in vitro experiments allow us to to obtaining basic enzymological constants will facilitate the study specify the activities of individual caspases, a goal not readily of proteolysis and other posttranslational modifications in complex achieved in cellular studies where many caspases are simulta- mixtures. neously activated. Conversely, the cellular studies include exogen- ous factors, such as subcellular compartmentalization, that may apoptosis ∣ caspase ∣ enzymology ∣ mass spectrometry ∣ selected reaction affect cleavage rates. monitoring Quantitative Measurement of Caspase-Cleaved Substrates. Our ana- poptosis is a form of programmed cell death that serves to lysis of proteolysis substrates is based on a previously described Aeliminate unnecessary, infected, or tumorigenic cells from N-terminal isolation platform that compares cells or lysates eukaryotic organisms. While many intrinsic and extrinsic stimuli before and after initiating a proteolytic process (3, 9, 10). Briefly, can initiate apoptosis, these ultimately converge on the activation free N termini in lysates are enzymatically labeled with a biotiny- of a related family of aspartate-specific cysteine proteases, the lated peptide ester, captured on neutravidin beads, and trypsinized caspases, that execute widespread proteolysis and induce nonin- to produce N-terminal peptides. The peptides are released by flammatory death (1). We and others have surveyed N termini site-specific proteolysis with Tobacco Etch Virus (TEV) protease, that occur in apoptotic cells and collectively reported more than and the N-terminal sequence identified via LC-MS/MS. Here, we 1,000 caspase-derived cleavages (2–5). This explosion of proteomic further optimized the tagging peptide to contain an aminobutyric data has defined a vast array of caspase substrates proteolyzed dur- acid residue at the P1 position instead of the serine-tyrosine tag ing apoptosis. While these data identify caspase targets, and in previously employed (Fig. S1) (4). This improvement resulted in some cases the sites of proteolysis, they fail to reveal the relative fewer tag-specific fragments and provided a nonnatural mass sig- rates of cleavage, a parameter necessary to establish the order of nature. Cleavages after aspartic acid residues are rare in healthy proteolytic events and their importance in extracts and intact cells. cell lysates (approximately 1% of N termini), so virtually all aspar- The recent application of selected reaction monitoring (SRM) methods, traditionally used for metabolite identification, to Author contributions: N.J.A., S.M., J.C.T., A.L.B., and J.A.W. designed research; N.J.A., S.M., proteomic studies has enabled the simultaneous label-free quan- and J.C.T. performed research; N.J.A., S.M., J.C.T., A.J.L., and A.L.B. contributed new tification of hundreds of peptides (6, 7). Our development of a reagents/analytic tools; N.J.A., S.M., J.C.T., and J.A.W. analyzed data; N.J.A. and J.A.W. N-terminal enrichment platform (3) is ideally suited to the appli- wrote the paper. cation of SRM to apoptotic proteolysis. Using this platform, The authors declare no conflict of interest. we have characterized approximately 1,000 caspase-derived pep- *This Direct Submission article had a prearranged editor. tides from human apoptotic cells forming a basis from which to 1To whom correspondence should be addressed. E-mail: [email protected]. establish high-confidence mass spectrometric assays for SRM. This article contains supporting information online at www.pnas.org/lookup/suppl/ BIOCHEMISTRY Additionally, our positive enrichment technology generates sam- doi:10.1073/pnas.1117158109/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1117158109 PNAS ∣ February 7, 2012 ∣ vol. 109 ∣ no. 6 ∣ 1913–1918 Downloaded by guest on September 30, 2021 tic-cleavages identified in apoptotic cells (typically 20–50% of total inal isolation protocol (3, 7). Additionally, the positive enrich- identified N termini) are due to caspase activities. ment for N termini significantly decreases sample complexity, To expand this technology to kinetic analysis required quanti- facilitating the development of unambiguous peptide quantifica- fication of these isolated N termini as a function of time. Tradi- tion assays. tional isotope encoded approaches to MS-based quantification To track hundreds of caspase proteolysis events across many (e.g. SILAC and iTRAQ) can monitor relative peptide abun- conditions, we developed assays to quantify N-terminal peptides dance (11, 12). However, these approaches are expensive, chal- isolated from apoptotic Jurkat cells. Investigation of intrinsic lenging to expand to more than a few samples, and often fail to (staurosporine) or extrinsic (TRAIL) inducers of apoptosis quantify the same peptide across multiple samples due to variable identified 1,341 peptides with caspase-like cleavage sites from sampling at the MS-level (13, 14). Thus we investigated selected a total of 3,892 high-confidence peptides (false discovery rate of reaction monitoring (SRM) (6), as a targeted label-free quanti- <1%) (Fig. 1A and Dataset S1 a and b) (15). We analyzed the fication approach for tracking caspase-mediated proteolysis. same fractions across the same chromatography on a QTRAP SRM quantification necessitates both prior identification of the mass spectrometer, monitoring up to 10 coeluting parent ion/ species of interest and reliable MS fragmentation patterns, two fragment ion (Q1/Q3) pairs (transitions) and optimizing the tran- requirements addressed by previous applications of our N-term- sition’s collision energies (Supporting Information). The presence Abu-LAPNVTYSLPR Fragments A y10 y9 y6 y8 y7 SRM y6 y5 736.3791 +2 b5 y9 qualification & transition
Recommended publications
  • Apoptotic Threshold Is Lowered by P53 Transactivation of Caspase-6
    Apoptotic threshold is lowered by p53 transactivation of caspase-6 Timothy K. MacLachlan*† and Wafik S. El-Deiry*‡§¶ʈ** *Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, and Departments of ‡Medicine, §Genetics, ¶Pharmacology, and ࿣Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 Communicated by Britton Chance, University of Pennsylvania School of Medicine, Philadelphia, PA, April 23, 2002 (received for review January 11, 2002) Little is known about how a cell’s apoptotic threshold is controlled Inhibition of the enzyme reduces the sensitivity conferred by after exposure to chemotherapy, although the p53 tumor suppres- overexpression of p53. These results identify a pathway by which sor has been implicated. We identified executioner caspase-6 as a p53 is able to accelerate the apoptosis cascade by loading the cell transcriptional target of p53. The mechanism involves DNA binding with cell death proteases so that when an apoptotic signal is by p53 to the third intron of the caspase-6 gene and transactiva- received, programmed cell death occurs rapidly. tion. A p53-dependent increase in procaspase-6 protein level al- lows for an increase in caspase-6 activity and caspase-6-specific Materials and Methods Lamin A cleavage in response to Adriamycin exposure. Specific Western Blotting and Antibodies. Immunoblotting was carried out by inhibition of caspase-6 blocks cell death in a manner that correlates using mouse anti-human p53 monoclonal (PAb1801; Oncogene), with caspase-6 mRNA induction by p53 and enhances long-term rabbit anti-human caspase-3 (Cell Signaling, Beverly, MA), mouse survival in response to a p53-mediated apoptotic signal.
    [Show full text]
  • XIAP's Profile in Human Cancer
    biomolecules Review XIAP’s Profile in Human Cancer Huailu Tu and Max Costa * Department of Environmental Medicine, Grossman School of Medicine, New York University, New York, NY 10010, USA; [email protected] * Correspondence: [email protected] Received: 16 September 2020; Accepted: 25 October 2020; Published: 29 October 2020 Abstract: XIAP, the X-linked inhibitor of apoptosis protein, regulates cell death signaling pathways through binding and inhibiting caspases. Mounting experimental research associated with XIAP has shown it to be a master regulator of cell death not only in apoptosis, but also in autophagy and necroptosis. As a vital decider on cell survival, XIAP is involved in the regulation of cancer initiation, promotion and progression. XIAP up-regulation occurs in many human diseases, resulting in a series of undesired effects such as raising the cellular tolerance to genetic lesions, inflammation and cytotoxicity. Hence, anti-tumor drugs targeting XIAP have become an important focus for cancer therapy research. RNA–XIAP interaction is a focus, which has enriched the general profile of XIAP regulation in human cancer. In this review, the basic functions of XIAP, its regulatory role in cancer, anti-XIAP drugs and recent findings about RNA–XIAP interactions are discussed. Keywords: XIAP; apoptosis; cancer; therapeutics; non-coding RNA 1. Introduction X-linked inhibitor of apoptosis protein (XIAP), also known as inhibitor of apoptosis protein 3 (IAP3), baculoviral IAP repeat-containing protein 4 (BIRC4), and human IAPs like protein (hILP), belongs to IAP family which was discovered in insect baculovirus [1]. Eight different IAPs have been isolated from human tissues: NAIP (BIRC1), BIRC2 (cIAP1), BIRC3 (cIAP2), XIAP (BIRC4), BIRC5 (survivin), BIRC6 (apollon), BIRC7 (livin) and BIRC8 [2].
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • HMGB1 in Health and Disease R
    Donald and Barbara Zucker School of Medicine Journal Articles Academic Works 2014 HMGB1 in health and disease R. Kang R. C. Chen Q. H. Zhang W. Hou S. Wu See next page for additional authors Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles Part of the Emergency Medicine Commons Recommended Citation Kang R, Chen R, Zhang Q, Hou W, Wu S, Fan X, Yan Z, Sun X, Wang H, Tang D, . HMGB1 in health and disease. 2014 Jan 01; 40():Article 533 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/533. Free full text article. This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. Authors R. Kang, R. C. Chen, Q. H. Zhang, W. Hou, S. Wu, X. G. Fan, Z. W. Yan, X. F. Sun, H. C. Wang, D. L. Tang, and +8 additional authors This article is available at Donald and Barbara Zucker School of Medicine Academic Works: https://academicworks.medicine.hofstra.edu/articles/533 NIH Public Access Author Manuscript Mol Aspects Med. Author manuscript; available in PMC 2015 December 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Mol Aspects Med. 2014 December ; 0: 1–116. doi:10.1016/j.mam.2014.05.001. HMGB1 in Health and Disease Rui Kang1,*, Ruochan Chen1, Qiuhong Zhang1, Wen Hou1, Sha Wu1, Lizhi Cao2, Jin Huang3, Yan Yu2, Xue-gong Fan4, Zhengwen Yan1,5, Xiaofang Sun6, Haichao Wang7, Qingde Wang1, Allan Tsung1, Timothy R.
    [Show full text]
  • P53 and the Cathepsin Proteases As Co-Regulators of Cancer and Apoptosis
    cancers Review Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis Surinder M. Soond 1,*, Lyudmila V. Savvateeva 1, Vladimir A. Makarov 1, Neonila V. Gorokhovets 1, Paul A. Townsend 2 and Andrey A. Zamyatnin, Jr. 1,3,4,* 1 Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Trubetskaya Str. 8-2, 119991 Moscow, Russia; [email protected] (L.V.S.); [email protected] (V.A.M.); gorokhovets_n_v@staff.sechenov.ru (N.V.G.) 2 Division of Cancer Sciences and Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, and the NIHR Manchester Biomedical Research Centre, Manchester M13 9PL, UK; [email protected] 3 Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia 4 Department of Biotechnology, Sirius University of Science and Technology, 1 Olympic Ave, 354340 Sochi, Russia * Correspondence: [email protected] (S.M.S.); [email protected] (A.A.Z.J.) Received: 6 October 2020; Accepted: 19 November 2020; Published: 22 November 2020 Simple Summary: This article describes an emerging area of significant interest in cancer and cell death and the relationships shared by these through the p53 and cathepsin proteins. While it has been demonstrated that the p53 protein can directly induce the leakage of cathepsin proteases from the lysosome, directly triggering cell death, little is known about what factors set the threshold at which the lysosome can become permeabilized. It appears that the expression levels of cathepsin proteases may be central to this process, with some of them being transcriptionally regulated by p53.
    [Show full text]
  • The Role of Caspase-2 in Regulating Cell Fate
    cells Review The Role of Caspase-2 in Regulating Cell Fate Vasanthy Vigneswara and Zubair Ahmed * Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham B15 2TT, UK; [email protected] * Correspondence: [email protected] Received: 15 April 2020; Accepted: 12 May 2020; Published: 19 May 2020 Abstract: Caspase-2 is the most evolutionarily conserved member of the mammalian caspase family and has been implicated in both apoptotic and non-apoptotic signaling pathways, including tumor suppression, cell cycle regulation, and DNA repair. A myriad of signaling molecules is associated with the tight regulation of caspase-2 to mediate multiple cellular processes far beyond apoptotic cell death. This review provides a comprehensive overview of the literature pertaining to possible sophisticated molecular mechanisms underlying the multifaceted process of caspase-2 activation and to highlight its interplay between factors that promote or suppress apoptosis in a complicated regulatory network that determines the fate of a cell from its birth and throughout its life. Keywords: caspase-2; procaspase; apoptosis; splice variants; activation; intrinsic; extrinsic; neurons 1. Introduction Apoptosis, or programmed cell death (PCD), plays a pivotal role during embryonic development through to adulthood in multi-cellular organisms to eliminate excessive and potentially compromised cells under physiological conditions to maintain cellular homeostasis [1]. However, dysregulation of the apoptotic signaling pathway is implicated in a variety of pathological conditions. For example, excessive apoptosis can lead to neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, whilst insufficient apoptosis results in cancer and autoimmune disorders [2,3]. Apoptosis is mediated by two well-known classical signaling pathways, namely the extrinsic or death receptor-dependent pathway and the intrinsic or mitochondria-dependent pathway.
    [Show full text]
  • Caspase-7 Expanded Function and Intrinsic Expression Level Underlies Strain-Specific Brain Phenotype of Caspase-3-Null Mice
    The Journal of Neuroscience, November 3, 2004 • 24(44):9977–9984 • 9977 Development/Plasticity/Repair Caspase-7 Expanded Function and Intrinsic Expression Level Underlies Strain-Specific Brain Phenotype of Caspase-3-Null Mice Caroline Houde,1 Kathleen G. Banks,2 Nathalie Coulombe,3 Dita Rasper,3 Erich Grimm,3 Sophie Roy,1,4 Elizabeth M. Simpson,2 and Donald W. Nicholson1,4 1Biochemistry Department, McGill University, Montreal, Quebec H3G 1Y6, Canada, 2Centre for Molecular Medicine and Therapeutics, British Columbia Institute for Children’s and Women’s Health, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada, 3Merck Frosst Canada and Company, Pointe-Claire–Dorval, Quebec H9R 4P8, Canada, and 4Merck Research Laboratories, San Diego, California 92121 Caspase-3-deficient mice of the 129S1/SvImJ (129) strain show severe brain development defects resulting in brain overgrowth and perinatal lethality, whereas on the C57BL/6J (B6) background, these mice develop normally. We therefore sought to identify the strain- Ϫ Ϫ dependent ameliorating gene. We biochemically isolated caspase-7 from B6-caspase-3-null (Casp3 / ) tissues as being the enzyme with caspase-3-like properties and capability of performing a caspase-3 surrogate function, apoptotic DNA fragmentation. Moreover, we show that, in contrast to the human enzymes, mouse caspase-7 is as efficient as caspase-3 at cleaving and thus inactivating ICAD (inhibitor of caspase-activated DNase), the inhibitor of apoptotic DNA fragmentation. Low levels of caspase-7 expression and activation correlate with Ϫ Ϫ Ϫ Ϫ lack of DNA fragmentation in 129-Casp3 / apoptotic precursor neurons, whereas B6-Casp3 / cells, which can fragment their DNA, show higher levels of caspase-7 expression and activation.
    [Show full text]
  • Proteases to Die For
    Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Proteases to die for Vincent Cryns1 and Junying Yuan2,3 1Center for Endocrinology, Metabolism and Molecular Medicine, Northwestern University School of Medicine, Chicago, Illinois 60611 USA; 2Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 USA Apoptosis or programmed cell death (PCD) is a geneti- have identified two genes (ced-3 and ced-4) that are each cally regulated, cellular suicide mechanism that plays a required for the execution of cell death and one (ced-9) crucial role in development and in the defense of homeo- that inhibits cell death (Hengartner et al. 1992; Yuan and stasis. Cells respond to a variety of disparate signals by Horvitz 1992; Yuan et al. 1993). Mutational analyses of committing suicide through a series of dramatic but re- these genes in C. elegans have defined a sequential cell markably uniform events. Morphologically, cells under- death pathway. Inactivating mutations of ced-9 result in going apoptosis demonstrate nuclear/cytoplasmic con- inappropriate cell deaths, but only if both ced-3 and densation and membrane protrusions. These initial ced-4 are functional (Hengartner et al. 1992). Targeted changes are followed by fragmentation of the nuclear overexpression of either ced-4 or ced-3 induces cell contents and subsequent encapsulation of these frag- death, these cell deaths are inhibited by ced-9. In trans- ments into ‘‘apoptotic bodies’’ that are quickly and un- genic worms, maximal cell death induced by ced-4 over- obtrusively consumed by adjacent cells, thereby leaving expression requires ced-3, whereas ced-3-mediated cell little trace of the apoptotic cell’s prior existence (Kerr et death is independent of ced-4.
    [Show full text]
  • Bax Transmembrane Domain Interacts with Prosurvival Bcl-2 Proteins in Biological Membranes
    Bax transmembrane domain interacts with prosurvival Bcl-2 proteins in biological membranes Vicente Andreu-Fernándeza,b,c, Mónica Sanchoa, Ainhoa Genovésa, Estefanía Lucendoa, Franziska Todtb, Joachim Lauterwasserb,d, Kathrin Funkb,d, Günther Jahreise, Enrique Pérez-Payáa,f,1, Ismael Mingarroc,2, Frank Edlichb,g,2, and Mar Orzáeza,2 aLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, E-46012 Valencia, Spain; bInstitute for Biochemistry and Molecular Biology, University of Freiburg, 79104 Freiburg, Germany; cDepartament de Bioquímica i Biologia Molecular, Estructura de Recerca Interdisciplinar en Biotecnología i Biomedicina, Universitat de València, 46100 Burjassot, Spain; dFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany; eDepartment of Biochemistry/Biotechnology, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany; fInstituto de Biomedicina de Valencia, Instituto de Biomedicina de Valencia–Consejo Superior de Investigaciones Científicas, 46010 Valencia, Spain; and gBIOSS, Centre for Biological Signaling Studies, University of Freiburg, 79104 Freiburg, Germany Edited by William F. DeGrado, School of Pharmacy, University of California, San Francisco, CA, and approved November 29, 2016 (received for review July 28, 2016) The Bcl-2 (B-cell lymphoma 2) protein Bax (Bcl-2 associated X, across bilayers via changes in the oligomeric state or protein con- apoptosis regulator) can commit cells to apoptosis via outer mito- formation (22–24). The Bax TMD targets fusion proteins to the chondrial membrane permeabilization. Bax activity is controlled in OMM; its deletion results in cytosolic Bax localization and impaired healthy cells by prosurvival Bcl-2 proteins. C-terminal Bax trans- Bax activity (25). Analysis of the active Bax membrane topology membrane domain interactions were implicated recently in Bax pore suggests that the TMD could play a central role in Bax oligomeri- formation.
    [Show full text]
  • Cordycepin Induces Apoptosis in Human Liver Cancer Hepg2 Cells Through Extrinsic and Intrinsic Signaling Pathways
    ONCOLOGY LETTERS 12: 995-1000, 2016 Cordycepin induces apoptosis in human liver cancer HepG2 cells through extrinsic and intrinsic signaling pathways LE-WEN SHAO1, LI-HUA HUANG1, SHENG YAN2, JIAN-DI JIN3 and SHAO-YAN REN3 1Nursing Department; Departments of 2Hepato-Biliary-Pancreatic Surgery and 3Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China Received March 6, 2015; Accepted April 12, 2016 DOI: 10.3892/ol.2016.4706 Abstract. Cordycepin, also termed 3'-deoxyadenosine, is a to have natural medicinal properties, such as anti-angiogenic, nucleoside analogue from Cordyceps sinensis and has been anti‑tumor, anti‑viral, anti‑inflammatory and hypoglycemic reported to demonstrate numerous biological and pharma- effects (1-8). cological properties. Our previous study illustrated that the Cordycepin, also termed 3'-deoxyadenosine, is a nucleo- anti-tumor effect of cordycepin may be associated with apop- side analogue from C. militaris (9) and has been reported tosis. In the present study, the apoptotic effect of cordycepin to demonstrate numerous notable biological and pharma- on HepG2 cells was investigated using 4',6-diamidino-2-phe- cological properties, including immunological stimulation, nylindole, tetraethylbenzimidazolylcarbocyanine iodide and anti-cancer and anti-viral effects (10-15), a stimulating effect propidium iodide staining analysis and flow cytometry. The on interlukin-10 production as an immune modulator (16) and results showed that cordycepin exhibited the ability to inhibit preventing hyperlipidermia (17). HepG2 cells in a time- and dose-dependent manner when cells Apoptosis, also termed programmed cell death, is a key produced typical apoptotic morphological changes, including regulator of tissue homeostasis and is characterized by chromatin condensation, the accumulation of sub-G1 cells and typical morphological and biochemical hallmarks, including change mitochondrial permeability.
    [Show full text]
  • Patched Dependence Receptor Triggers Apoptosis Through Ubiquitination of Caspase-9
    Patched dependence receptor triggers apoptosis through ubiquitination of caspase-9 Joanna Fombonnea,1, Pierre-Antoine Bisseya,1, Catherine Guixa, Rémy Sadoulb, Chantal Thibertb, and Patrick Mehlena,2 aApoptosis, Cancer and Development Laboratory-Equipe labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Cancérologie de Lyon, Institut National de la Santé et de la Recherche Médicale U1052-Centre National de la Recherche Scientifique Unité Mixte de Recherche 5286, Centre Léon Bérard, Université de Lyon, 69008 Lyon, France; and bNeurodegenerescence and Plasticity Laboratory-Institut des Neurosciences, Institut National de la Santé et de la Recherche Médicale U836, Université Joseph Fourier, 38042 Grenoble, France Edited* by Bert Vogelstein, The Johns Hopkins University, Baltimore, MD, and approved April 30, 2012 (received for review January 4, 2012) Patched (Ptc), the main receptor for Sonic Hedghog, is a tumor (E3), such as Nedd4. Ubiquitination was initially described to suppressor. Ptc has been shown to be a dependence receptor, play a major role in protein degradation by providing a signal for and as such triggers apoptosis in the absence of its ligand. This proteasome-mediated degradation. However, it has been shown apoptosis induction occurs through the recruitment by the Ptc in- recently that ubiquitination is important not only for protein tracellular domain of a caspase-activating complex, which includes degradation but also for the regulation of both prosurvival and the adaptor proteins DRAL and TUCAN, and the apical caspase-9. proapoptotic signals (13–15). Considering recent data describing We show here that this caspase-activating complex also includes the ubiquitination of caspase-8 as a mechanism for caspase-8 the E3 ubiquitin ligase NEDD4.
    [Show full text]
  • Caspase-6 Induces 7A6 Antigen Localization to Mitochondria During FAS-Induced Apoptosis of Jurkat Cells HIROAKI SUITA, TAKAHISA SHINOMIYA and YUKITOSHI NAGAHARA
    ANTICANCER RESEARCH 37 : 1697-1704 (2017) doi:10.21873/anticanres.11501 Caspase-6 Induces 7A6 Antigen Localization to Mitochondria During FAS-induced Apoptosis of Jurkat Cells HIROAKI SUITA, TAKAHISA SHINOMIYA and YUKITOSHI NAGAHARA Division of Life Science and Engineering, School of Science and Engineering, Tokyo Denki University, Hatoyama, Japan Abstract. Background: Mitochondria are central to caspases (caspase-8 and -9) that activate effector caspases (1). apoptosis. However, apoptosis progression involving Caspases are constructed of a pro-domain, a large subunit, and mitochondria is not fully understood. A factor involved in a small subunit. Upon caspase activation, cleavage of the mitochondria-mediated apoptosis is 7A6 antigen. 7A6 caspase occurs. Caspase-6 and -7, which are effector caspases, localizes to mitochondria from the cytosol during apoptosis, each have a large subunit that is 20 kDa (p20) and a small which seems to involve ‘effector’ caspases. In this study, we subunit that is 10 kDa (p10), but caspase-3, which is also an investigated the precise role of effector caspases in 7A6 effector caspase, has a large subunit of 17 kDa and a small localization to mitochondria during apoptosis. Materials and subunit of 12 kDa (p12) (2-4). Moreover, the large and small Methods: Human T-cell lymphoma Jurkat cells were treated subunits of caspase-6 and -7 are connected by a linker, but with an antibody against FAS. 7A6 localization was analyzed caspase-3 does not have a linker (Figure 1). The difference by confocal laser scanning microscopy and flow cytometry. between effector and initiator caspases is that the pro-domain Caspases activation was determined by western blot of an initiator caspase is long and that the pro-domain of an analysis.
    [Show full text]